Isozyme-specific enzyme inhibitors. 14. 5'(R)-C-[(L-homocystein-S-yl)methyl]adenosine 5'-(.beta.,.gamma.-imidotriphosphate), a potent inhibitor of rat methionine adenosyltransferases

Publisher Website
Google Scholar
Abstract
The title compound is a covalent adduct of L-methionine (Met) and .beta.,.gamma.-imido-ATP. In its synthesis the N-Boc derivative of 5''(R)-C-(aminomethyl)-N6-benzoyl-5''-O-tosyl-2'',3''-O-isopropylideneadenosine was converted by the successive actions of CF3CO2H and HNO2 into the corresponding 5''(R)-C-hydroxymethyl derivative. Treatment of this with disodium L-homocysteinate led to attack of sulfur at C6'', apparently via a 5'',6''-epoxide, and to total stereoselective inversion at C5'' to furnish, after debenzoylation, 5''(R)-C-(L-homocystein-S-ylmethyl)-2'',3''-O-isopropylideneadenosine. The 5'' configuration was established by conversion of this into the known 5''(S)-C-methyl-2'',3''-O-isopropylidene adenosine with Raney nickel. The .alpha.-amino acid residue was protected as an N-Boc methyl ester, after which the 5''-hydroxyl was phosphorylated with benzyl phosphate and dicyclohexylcarbodiimide. The phosphoanhydride bond with inorganic imidodiphosphate was then created by established methods. Finally, blocking groups were removed under conditions that gave the desired adduct with no racemization of its L-methionine residue. It was a potent inhibitor [KM(ATP)/Ki = 1080; KM(Met)/Ki = 7.7 ] of the M-2 (normal tissue) form of rat methionine adenosyltransferase and of the M-T (hepatoma tissue) form [KM(ATP)/Ki = 670; KM(Met)/Ki = 22]. Inhibitions were competitive with respect to ATP or to L-methionine, indicating a dual substrate site mode of binding to the enzyme forms.

This publication has 28 references indexed in Scilit: